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Dietary intervention constitutes a feasible approach
for modulating metabolism and improving the health
span and lifespan.Methionine restriction (MR) delays
the appearance of age-related diseases and in-
creases longevity in normal mice. However, the
effect of MR on premature aging remains to be eluci-
dated. Here, we describe that MR extends lifespan in
two different mouse models of Hutchinson-Gilford
progeria syndrome (HGPS) by reversing the tran-
scriptome alterations in inflammation and DNA-dam-
age response genes present in this condition.
Further, MR improves the lipid profile and changes
bile acid levels and conjugation, both in wild-type
and in progeroid mice. Notably, treatment with cholic
acid improves the health span and lifespan in vivo.
These results suggest the existence of a metabolic
pathway involved in the longevity extension achieved
byMR and support the possibility of dietary interven-
tions for treating progeria.INTRODUCTION
Over the past years, multiple studies have confirmed the idea
that caloric restriction (CR), i.e., a reduction of caloric intake
without malnutrition, can delay aging in numerous model organ-
isms (Fontana and Partridge, 2015; Madeo et al., 2015). Thus,
CR has been proven to act efficiently on several hallmarks of ag-
ing, enhancing metabolic flexibility, stem cell function, and DNA2392 Cell Reports 24, 2392–2403, August 28, 2018 ª 2018 The Autho
This is an open access article under the CC BY-NC-ND license (http://repair and reducing inflammation and age-related diseases (Fin-
kel, 2015; Lo´pez-Otı´n et al., 2013, 2016; Mitchell et al., 2016).
Activation of AMPK, SIRT1, and the autophagy response and
suppression of the growth hormone (GH)/IGF1 and mTOR
signaling pathways have been implicated in the extension of
the health span observed under CR (Breese et al., 1991; Burke-
witz et al., 2014; Dunn et al., 1997; Fontana et al., 2016; Galluzzi
et al., 2014; Johnson et al., 2013; Mercken et al., 2014; Stenesen
et al., 2013). Recently, it has been described that CR extends the
lifespan in a DNA-repair-deficient mouse model by reducing
genomic stress (Vermeij et al., 2016). However, the underlying
molecular pathways at the core of CR interventions remain
incompletely defined. In this regard, the study of macronutrient
restriction accomplished by the reduction of specific constitu-
ents of the diet instead of a simple and non-specific decrease
in calorie intake has gained attention in recent years. Thus, re-
striction of proteins or certain amino acids in the diet can reduce
the incidence of age-associated diseases and simultaneously in-
crease lifespan (Mirzaei et al., 2014; Nakagawa et al., 2012; So-
lon-Biet et al., 2015). Among these, methionine restriction (MR) is
supposed to exert its benefits, at least in part, through the sup-
pression of the GH/IGF1 somatotrophic axis (Miller et al.,
2005). MR also modulates mitochondrial activity, which, in
turn, leads to an increase in both respiration rate (an increment
of VO2 and VCO2) and energy expenditure (Orgeron et al.,
2014) and increases the levels of hydrogen sulfide (H2S), a mole-
cule that is indispensable for lifespan extension under CR (Hine
et al., 2015).
The effects of amino acid restriction have been assessed in
normal aging yet remain unexplored in genetic models of accel-
erated aging. Hutchinson-Gilford progeria syndrome (HGPS) is a
rare premature aging condition in which a point mutation in thers.
creativecommons.org/licenses/by-nc-nd/4.0/).
LMNA gene causes the accumulation at the nuclear envelope of
an aberrant precursor of lamin A, named progerin (Eriksson et al.,
2003; De Sandre-Giovannoli et al., 2003). Children with HGPS
manifest growth impairment, lipodystrophy, and dermal and
bone abnormalities, as well as cardiovascular alterations that
lead to an average life expectancy of 13 years (Gordon et al.,
2014). Of note, during normal human aging, ever-increasing
amounts of progerin are produced as a result of LMNA aberrant
alternative splicing, suggesting that progerin not only partici-
pates in the pathogenesis of HGPS but may also contribute to
normal aging (Burtner and Kennedy, 2010; Scaffidi and Misteli,
2006). We have generated a mouse model carrying the equiva-
lent of the most common human HGPS-associated mutation,
p.Gly608Gly (p.Gly609Gly in mice). This model phenocopies
most alterations observed in children with HGPS (Osorio et al.,
2011). So far, the main manipulations that have led to an
improvement of fitness and extension of lifespan in the
p.Gly609Gly mouse model of HGPS have been a morpholino-
based therapy that reduces progerin accumulation (Osorio
et al., 2011), genetic or pharmacological attenuation of inflam-
mation (Osorio et al., 2012), interruption of lamin A-progerin
binding (Lee et al., 2016), inhibition of the acetyltransferase
NAT10 (Balmus et al., 2018), and in vivo activation of reprogram-
ming (Ocampo et al., 2016).
Here, we report that a low-methionine diet can extend health
span and lifespan in the HGPS mouse model by ameliorating
the alterations in signaling pathways,such as inflammation or
DNA damage. Moreover, we describe that MR improves meta-
bolic homeostasis and restores lipid and bile acid (BA) levels,
and that treatment with cholic acid improves health span and
lifespan in a mouse model of progeria. Together, our results sug-
gest that the use of dietary interventions can effectively influence
the metabolic deregulation of patients affected by accelerated
aging syndromes, providing beneficial effects that could improve
their quality of life and extend their longevity.
RESULTS
Methionine-Restricted Diet Extends Lifespan in a
Mouse Model of HGPS
Mice homozygous for the HGPS mutation (LmnaG609G/G609G in a
C57BL/6N background) were fed a diet with a low concentration
(0.12%) of methionine. This dietary intervention reduced mortal-
ity rate and extended the median lifespan in both male and fe-
male LmnaG609G/G609G progeroid mice by 20% (Figures 1A, 1B,
S1A, and S1B). Also, LmnaG609G/G609G mice fed an MR diet
showed a tendency toward an increased maximum survival by
approximately 20% (Figures 1A and S1C). As compared to
wild-type (WT) controls, LmnaG609G/G609G mice on a control
diet (CD) (LmnaG609G/G609G-CDmice) are characterized by a rela-
tively small size and low bodyweight (Osorio et al., 2011). Admin-
istration of the MR diet to LmnaG609G/G609G mice further
exacerbated these characteristics (Figure 1C). Although
LmnaG609G/G609G-CD mice usually died by the time they reached
a weight below 11 g, mice on the MR diet managed to survive
with a lower weight for several weeks (Figure 1D), suggesting
that small body size is not an obligatory predictor of health
span in progeria. Indeed, MR retarded the appearance of lordo-kyphosis and loss of grooming in LmnaG609G/G609G mice (Fig-
ure 1E). LmnaG609G/G609G mice showed a basal loss of bone tis-
sue due to inflammation-associated osteolysis, which is
reversed under pharmacological and genetic inhibition of inflam-
mation (Osorio et al., 2012). As expected, LmnaG609G/G609Gmice
with a CD showed a clear loss of bone tissue (Figures 1F and
S1D). However, with an MR diet, we found an extensive amelio-
ration of the phenotype with an almost complete recovery of
bone structure. MR in LmnaG609G/G609G mice enhanced bone
volume, number and connectivity of trabeculae, and bone min-
eral density in tibia, reaching values close to the normal ones
found in WT animals (Figures 1F and S1D). Histological analysis
showed that LmnaG609G/G609G-CD mice had aortic alterations
such as focal fibrosis withmild chronic infiltrate and an increment
of matrix between elastic fibers. These alterations were not pre-
sent in LmnaG609G/G609G-MR mice (Figure 1G). Also, although
both LmnaG609G/G609G mice on a CD and those on an MR diet
had atrophy of the gastric mucosa, LmnaG609G/G609G-CD mice
presented glandular dilatations and ulcerations (Figure 1G). At
the skeletal muscle, quadriceps, LmnaG609G/G609G-CD mice
had focal and perivascular fibrosis. Again, these alterations
were absent in mice that were fed an MR diet (Figure 1G).
Analysis of Classical CR-Modulated Longevity Pathways
in MR Progeria Mice
Similar to other mouse models of premature aging (Marin˜o et al.,
2010; Niedernhofer et al., 2006; van der Pluijm et al., 2007),
LmnaG609G/G609G mice display constitutive inhibition of the
GH/IGF1 (insulin growth factor 1) pathway (Figure 2A), although
an MR diet decreased glycemia under fasting conditions in both
genotypes (Figure 2B). Reminiscent of published results on CR
(Duffy et al., 1990; Heilbronn et al., 2006), MR caused a reduction
in body temperature in WT mice. When compared to WT con-
trols, however, LmnaG609G/G609Gmice that were kept on a CD ex-
hibited reduced body temperature (Figure 2C). Hence, a general
reduction of metabolic turnover cannot explain the beneficial ef-
fect of MR on the progeroid phenotype. Also, although an MR
diet enhanced AMPK and reduced mTORC1 activity in liver
from WT mice (Figures 2D and S2), similarly to another model
of HGPS (Marin˜o et al., 2008), LmnaG609G/G609G-CD mice ex-
hibited basal AMPK activation—demonstrated by its hyperphos-
phorylation—and an inhibition of mTORC1 in liver compared to
WTmice, indicated by the reduced phosphorylation of its targets
P70-S6K and AKTSer473 (Figures 2D and S2). Of note, an MR diet
induced a further decrease of AKTSer473 phosphorylation in
LmnaG609G/G609G mice, without changes in P70-S6K (Figures
2D and S2).
MR promotes an increase in respiration rates (VO2 and VCO2)
and energy expenditure, features that were observed inWTmice
fed an MR diet (Figures 2E–2G). On a CD, LmnaG609G/G609Gmice
exhibited a significant increment in respiration rates and energy
expenditure when compared to WT animals (Figures 2E–2G),
which could be explained as a possible strategy to increase
thermogenesis. MR only slightly increased these values in
LmnaG609G/G609Gmice (Figures 2E–2G). On the basis of these re-
sults, we conclude that LmnaG609G/G609G mice have a basal
activation of the pro-survival mechanisms of MR previously
described, involving the GH/IGF1 axis, the AMPK/mTORC1Cell Reports 24, 2392–2403, August 28, 2018 2393
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Figure 1. MR Enhances Lifespan and Health Span in LmnaG609G/G609G Mice
(A) Survival plot of LmnaG609G/G609G mice fed an MR diet (purple) or control diet (black) (n = 14 per group). Survival curves were analyzed with the log-rank
(Mantel-Cox) test (p = 0.0023) and Gehan-Breslow-Wilcoxon test (p = 0.0044).
(B) Mice fed an MR diet show a lower mortality rate. Slope of G609G-CD is 0.022, and slope of G609G-MR is 0.016. Curve comparison: p < 0.001.
(C) MR diet in LmnaG609G/G609G mice induces a smaller weight. *p < 0.05 (CD, n = 11; MR, n = 12).
(D) Weight loss during the 5 weeks before death. LmnaG609G/G609G-CDmice die by the time they reach a weight lower than 11 g, while LmnaG609G/G609G-MRmice
survive a lower weight. *p < 0.05 (n = 6 per group).
(E) LmnaG609G/G609G-MR mice present a deceleration of the aged phenotype, appreciated by a retardation of lordokyphosis and a longer maintenance of
grooming.
(F) Three-dimensional longitudinal and transversal images of tibias fromWT-CD, LmnaG609G/G609G-CD, and LmnaG609G/G609G-MR littermate mice, generated with
mCT analysis (n = 3 per group).
(G) Histological analysis of the aorta stained with orcein technique, gastric mucosa stained with H&E, and skeletal muscle (quadriceps) stained with H&E and
Gomori trichrome.
Error bars indicate SEM. Scale bars are indicated in each figure. See also Figure S1.energy sensors, thermoregulation, or general effects on energy
expenditure. Therefore, the positive effects of MR on these pro-
geroid mice cannot be explained exclusively by the classical CR
pathways and should involve additional mechanisms.
MR Attenuates the Transcriptome Alterations of
Progeroid Mice
To gain insight into the molecular mechanisms by which an MR
diet extends lifespan in progeroid mice, we analyzed the tran-
scriptome of liver tissues from fasted LmnaG609G/G609G and WT
mice kept on a CD or MR diet. We selected this tissue because
of its central metabolic function. Principal-component analysis
indicated clear distinctions between the two genotypes and
the two diets (Figure 3A). When compared to WT-CD, most
transcripts altered in WT-MR mice were similarly changed
in LmnaG609G/G609G-MR mice. By contrast, there were
more than 900 genes whose expression was altered in2394 Cell Reports 24, 2392–2403, August 28, 2018LmnaG609G/G609G-CD but not in LmnaG609G/G609G-MR mice, as
compared to that from WT-CD mice (Figure 3B). Additionally,
around 2,500 transcripts were changed in LmnaG609G/G609G-
MR mice and not in LmnaG609G/G609G-CD when compared to
WT-CD (Figure 3B), confirming a shift of the transcriptome
landscape due to the dietary modification. Gene set enrichment
analysis (GSEA) confirmed previously reported differences in
transcript levels between LmnaG609G/G609G and WT mice,
including those associated with the hyperactivation of inflamma-
tion and DNA-damage response pathways (Osorio et al., 2011,
2012), together with some undescribed downregulated
pathways such as fatty acid metabolism and BA metabolism
(Figure 3C). By comparing the transcript levels of
LmnaG609G/G609G-MR and LmnaG609G/G609G-CD, we found that
some of the pathways that were upregulated in progeroid
models were repressed by MR in LmnaG609G/G609G mice. This
applies to several groups of genes related to inflammation,
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Figure 2. MR Fails to Induce the Classical Survival Response in LmnaG609G/G609G Mice
(A) Reduced basal levels of IGF1 in sera from LmnaG609G/G609G mice (WT, n = 3 per group; G609G = 4 per group).
(B) Glucose levels after a 5-hr fasting in the week 6 of treatment (n = 6 per group).
(C) Rectal temperature in week 6 of treatment (n = 6 per group).
For (A)–(C), lines in dot plots indicate mean ± SEM.
(D)Western blot analysis of phosphorylated (P)-AMPK, total AMPK, P-P70S6K, total P70S6K, P-AKT (ser473), and total AKT in liver protein extracts. TheWestern
blots shown were carried out with the same samples run in parallel in three blots: one for P- and total (T)-AMPK, one for P- and T-P70S6K, and a third blot for P-
and T-AKT and a-tubulin. All membranes were stained with Ponceau to confirm equal protein loading and homogeneous transfer.
(E–G). Indirect calorimetry. (E) VO2 consumption (milliliters per kilogram per hour); (F) VCO2 production (milliliters per kilogram per hour); and (G) energy
expenditure (kilocalories per kilogram per hour) during 24 hr (n = 4 per group). Quantification of the area under the curve (AUC) of each parameter is provided
below in boxplots (n = 4). *p < 0.05; **p < 0.01; ***p < 0.001.
See also Figure S2.such as the interferon alpha and gamma response, tumor necro-
sis factor alpha (TNFA) signaling via nuclear factor kB (NF-kB),
and interleukin-6 (IL-6), JAK, and STAT3 signaling. Also, DNA
repair, BA metabolism, apoptosis, and p53 pathways were
reduced by MR in LmnaG609G/G609G mice (Figure 3D).
Next, we compared the transcriptome profiles of
LmnaG609G/G609G mice on either a CD or an MR diet with those
of WT mice on a CD. Several pathways that are altered in the
LmnaG609G/G609G-CD mice with respect to WT controls were
completely or partially rescued by MR (Figure 3E), as indicated
by the fact that the GSEA-normalized enrichment score (NES)
for LmnaG609G/G609G-MR mice was opposite to the NES for
LmnaG609G/G609G-CD mice. This applies for IL-6, JAK, andSTAT3 signaling, TNFA signaling via NF-kB, coagulation, com-
plement, and KRAS signaling, indicating that MR was able to
counteract progeria-associated changes in these pathways.
For other pathways, such as fatty acid metabolism, apoptosis,
E2F targets, and DNA repair, the NES values showed a partial
improvement of the progeroid transcriptome upon MR
(Figure 3E).
To identify possible genotype-specific responses, we per-
formed GSEA of transcript levels from WT-MR versus WT-CD
mice (Figure S3A). Most pathways were altered in the same
direction as in LmnaG609G/G609G-MR mice. Thus, mTORC1
signaling and xenobiotic, fatty acid and heme metabolism path-
ways were upregulated, whereas coagulation, complement, andCell Reports 24, 2392–2403, August 28, 2018 2395
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Figure 3. MR Restores the Transcriptome of LmnaG609G/G609G Mice
(A) Multidimensional scaling showed that the individual cases of our dataset were grouped according to the corresponding genotype and diet.
(B) Proportional Venn diagram illustrating that most of the transcripts modified by the MR diet were shared between LmnaG609G/G609G and WT mice.
(C and D) GSEA NES analysis of (C) LmnaG609G/G609G -CD versus WT-CD and (D) LmnaG609G/G609G -CD versus LmnaG609G/G609G-MR mice. Red indicates
upregulated pathways, and blue indicates downregulated pathways.
(E) GSEA NES comparison of LmnaG609G/G609G-CD mice versus WT-CD mice and LmnaG609G/G609G-MR mice versus WT-CD mice.
See also Figure S3.interferon alpha and gamma response signaling were downregu-
lated by MR. However, several other pathways were affected by
MR inWT and LmnaG609G/G609Gmice in opposite directions. This
applied to pathways related to DNA damage (p53 pathway, DNA
repair, and apoptosis) and inflammation (TNFA signaling via NF-
kB and IL-6, JAK, STAT3 signaling), whichwere increased byMR
inWTmice yet reduced in LmnaG609G/G609Gmice. This difference
might be related to the basal hyperactivation of these pathways
in LmnaG609G/G609Gmice on a CD (Figure 3C) (Osorio et al., 2011,
2012). Collectively, the aforementioned results indicate that MR
attenuates or reverts several of the transcriptome alterations that
accompany the phenotypic changes resulting from the
LmnaG609G/G609G mutation, especially those accounting for
inflammation and DNA-damage signaling.
MR Normalizes the Metabolome and Improves the Lipid
Profile in the HGPS Mouse Model
To deepen the study of the changes induced by MR in both WT
and progeroid mice, we performed mass spectrometric metab-
olome profiling in livers from fasted WT and LmnaG609G/G609G
mice kept on a CD or an MR diet. This revealed clear genotype
and diet effects, as determined bymultidimensional scaling (Fig-2396 Cell Reports 24, 2392–2403, August 28, 2018ure 4A) and unsupervised hierarchical clustering and heatmap
analysis (Figure S4A). These results closely resemble those
derived from the analysis of transcript levels, suggesting that
the dietary intervention has more impact on metabolism than
the Lmna mutation.
Examination of individual metabolites showed that MR
depleted the methionine derivatives taurine, hypotaurine, and
5-methylthioadenosine. Thus, MR caused a 20-fold downregula-
tion of taurine in WT and an 11-fold downregulation in
LmnaG609G/G609G livers, together with an increment in glycine
(Figures 4B, S4B, and S4C). MR also reduced quinolinic acid
and phosphoserine (Figures 4B and S4B). Conversely, MR
caused an increase in the polyamine spermidine by 10-fold in
LmnaG609G/G609G livers (Figure 4B). Along with the increment in
spermidine, MR caused an increase in some modified amino
acids such as leucylproline and g-glutamylleucine, intermediates
of protein catabolism, as well as in dimethylglycine, which partic-
ipates in choline and methionine metabolism (Figures 4B and
S4B). MR also increased glycerophosphorylcholine, a choline
derivative that plays a major role in osmotic balance (Figure 4B).
In summary, an assessment of individual metabolites suggests
that MR attenuates the difference between the metabolic
A B E F
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Figure 4. MR Restores Metabolome and Lipid Levels in LmnaG609G/G609G Mice
(A) Multidimensional scaling of the samples from the metabolomics analysis grouped according to the corresponding genotype and diet.
(B) Volcano plot showing the most differentially changed metabolites in LmnaG609G/G609-MR compared to LmnaG609G/G609G-CD mice. Upregulated metabolites
are indicated in red, and downregulated metabolites are indicated in blue.
(C and D) Metabolic enrichment analysis showing (C) pathways downregulated in LmnaG609G/G609G-CD compared toWT-CDmice and (D) pathways upregulated
in LmnaG609G/G609G-MR compared to LmnaG609G/G609G-CD mice.
(E) Serum free fatty acid levels (in micromolar) (n = 3 per group).
(F) Liver triglyceride levels (n = 5 per group).
For (E) and (F), lines in dot plots indicate mean ± SEM.
(G) Relative liver levels of MUFAs (heptadecenoic (C17:1), nonadecenoic (C19:1) and oleic acid (C18:1)) and PUFAs (linoleic (C18:2) and eicosadienoic acid
(C20:2)) in WT-CD, WT-MR, LmnaG609G/G609G-CD, and LmnaG609G/G609G-MRmice (WT, n = 4 per group; G609G, n = 5 per group). Levels represent the log2 of the
normalized area in a.u. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
See also Figure S4 and Table S1.landscapes from WT and LmnaG609G/G609G mice, inducing
similar metabolic changes in both phenotypes.
Enrichment analyses using MetaboAnalyst led to the identifi-
cation of pathways that were downregulated in LmnaG609G/G609G
samples as compared to WT controls and that were reinstated
by MR in the progeroid mice: biosynthesis of unsaturated fatty
acids, glycerophospholipid metabolism, linoleic and alpha-lino-
lenic acid metabolism, and ascorbate and aldarate metabolism
(Figures 4C and 4D). Remarkably, in the aforementioned micro-
array analysis, we found that the expression of genes involved in
fatty acid metabolismwas reduced in LmnaG609G/G609G-CDmice
when compared to WT-CD mice and was partially recovered in
LmnaG609G/G609G-MR mice (Figures 3C and 3E). Among the mol-
ecules that were most reduced in LmnaG609G/G609G-CD mice
compared to WT-CD mice, we detected several fatty acids,
such as palmitoleic, linoleic, oleic, and heptadecenoic acids (Fig-
ure S4D). Accordingly, we found that global serum free fatty
acids and liver triglycerides were reduced in LmnaG609G/G609G-
CD mice and partly recovered on an MR diet (Figures 4E and
4F). MR also caused the recovery of several polyunsatu-
rated (PUFAs) and monounsaturated fatty acids (MUFAs) inLmnaG609G/G609G mice, keeping their levels similar to those
in WT-MR mice (Figure 4G). Altogether, we conclude that
MR modifies the lipid profile in LmnaG609G/G609G mice and
restores lipid metabolic pathways that were repressed in proge-
roid mice.
MR in ProgeroidMice Increases BA Levels in Liver under
Fasting Conditions and Reverts the High Levels of
Taurine Conjugation
In themicroarray analysis described earlier, we also noted differ-
ences in BA metabolism at the transcriptional level in
LmnaG609G/G609G mice under a CD when compared to both
WT-CD and LmnaG609G/G609G-MR mice (Figures 3C and 3D).
The metabolomic profiling further allowed us to explore this
alteration, which revealed that cholic acid was downregulated
(11 times) in LmnaG609G/G609G-CDmice versusWT-CDmice (Fig-
ure S4D) yet upregulated by 7 and 12 times in LmnaG609G/G609G-
MR and WT-MR mice, respectively (Figure 5A). Notably, cholic
acid was upregulated 85-fold in LmnaG609G/G609G-MR mice
versus LmnaG609G/G609G-CD mice, being the metabolite most
induced by MR (Figures 4B and S4B). As shown earlier, taurineCell Reports 24, 2392–2403, August 28, 2018 2397
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Figure 5. Profiling BA Levels in Fasting and
Re-feeding Conditions Shows a Loss of Pri-
mary BAs in LmnaG609G/G609G Mice and an
Abnormal Increment in Taurine Conjugation
(A–C) Boxplots showing the (A) levels of cholic acid,
(B) taurocholate/taurine ratio, and (C) levels of de-
oxycholic acid under fasting conditions in liver sam-
ples fromWT-CD, WT-MR, LmnaG609G/G609G-CD and
LmnaG609G/G609G-MR (n = 5 per group). Levels of
cholic and deoxycholic acid are presented as the log2
of the normalized area in a.u. (AU).
(D–F) Boxplots showing the levels of (D) primary BAs,
(E) taurine-conjugated BAs, and (F) glycine-conju-
gated BAs in ileum samples from WT-CD, WT-MR,
LmnaG609G/G609G-CD and LmnaG609G/G609G-MR mice
under refeeding conditions (n = 8 per group). Levels
represent the log2 of the normalized area in a.u. Sex is
indicated with different symbols. aMCA, a-muricholic
acid; bMCA, b-muricholic acid; CDCA, chenodeox-
ycholic acid; CA, cholic acid; TaMCA, tauro-a-mur-
icholic acid; TCDCA, taurochenodeoxycholic acid;
TCA, taurocholic acid; TDCA, taurodeoxycholic
acid; TLCA, taurolithocholic acid; TUDCA, taur-
oursodeoxycholic acid; GCDCA, glycochenodeox-
ycholic acid; GCA, glycocholic acid; GDCA,
glycodeoxycholic acid; GUDCA, glycoursodeox-
ycholic acid.
*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. See
also Figure S5 and Table S2.was severely downregulated in progeroid mice under MR (Fig-
ures 4B and S4C); however, BAs conjugated with taurine, such
as taurocholic or taurodeoxycholic acid, were not changed
upon MR in liver (Figures S5A and S5B). This implied that the ra-
tio of taurocholic acid to taurine was remarkably upregulated in
both LmnaG609G/G609G and WT mice maintained on MR (Fig-
ure 5B). The secondary BA deoxycholic acid was also decreased
in LmnaG609G/G609G-CD mice versus WT-CDmice and increased
uponMR in both LmnaG609G/G609G andWTmice (Figure 5C), thus
exhibiting a pattern of modulation similar to that of cholic acid.
To understand the alteration of BAs in LmnaG609G/G609G
mice, we examined the mRNA expression levels of enzymes
involved in their generation, including those encoding compo-
nents of the cytochrome P450 complex (Lorbek et al., 2012).
mRNA expression analysis of Cyp7a1, Cyp7b1, Cyp8b1,
Cyp3a11, and Cyp39a1 in liver showed that the only enzyme
consistently activated in both WT and progeroid mice fed an
MR diet was Cyp39a1 (Figure S5C). Of note, Cyp39a1 is
involved in alternative pathways of BA synthesis (Lorbek
et al., 2012); in contrast, Cyp7b1 and Cyp8b1, key enzymes
in the classical and alternative synthesis pathway of BAs,
were repressed under an MR diet (Figure S5C). These results
suggest that the increment in BAs observed under an MR
diet does not depend on an increment of the synthesis path-
ways described so far.
To deepen the origin of the changes observed in BAs in WT
and progeroid mice on a CD and an MR diet, we profiled BA
levels in liver and ileum through targeted metabolomics under2398 Cell Reports 24, 2392–2403, August 28, 2018refeeding conditions, when BA synthesis is induced. We
observed that, under this nutritional condition, levels of primary
BAs in ileum were reduced in progeroid mice on both a CD and
an MR diet (Figure 5D); however, this trend was not observed in
liver (Figure S5D). These results suggest that the increment in
primary BAs observed in liver in MR-fed mice under fasting
conditions was not dependent on their synthesis. Indeed, no
differences were observed in the transcript levels of key
enzymes involved in the generation of BAs upon refeeding con-
ditions (Figure S5E). Remarkably, and similar to fasting condi-
tions, Cyp39a1 was the only enzyme induced by an MR diet
in both genotypes (Figure S5E). LmnaG609G/G609G-CD mice
had abnormally high levels of BAs conjugated with taurine in
ileum of both sexes (Figure 5E). On an MR diet, the levels of
taurine-conjugated BAs were lower (Figure 5E), probably due
to the taurine deficiency associated with the modified diet (Fig-
ure S4C). Conversely, both WT and LmnaG609G/G609G mice fed
the MR diet showed an increment in glycine-conjugated BAs,
such as glycochenodeoxycholic acid (GCDCA), glycocholic
acid (GCA), glycodeoxycholic acid (GDCA), and glycourso-
deoxycholic acid (GUDCA) (Figure 5F). Glycine-conjugated
BAs, which are usually found in much lower levels than
taurine-conjugated BAs, are not synthetized in mouse liver
but generated by the gut microbiome in the ileum. Collectively,
these results prove an alteration in the conjugation of BAs, with
an excess of taurine conjugation in LmnaG609G/G609G-CD mice
that is reversed in an MR diet, favoring this diet as an increment
in glycine-conjugated BAs.
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Figure 6. Both MR and In Vivo Modulation of BA Pool Exerts Beneficial Effects in Zmpste24/ Mouse Model of Progeria
(A) Zmpste24/ mice fed an MR diet (light and dark pink) show a lower weight than Zmpste24/ mice under a CD (black and gray) (n = 4 per group).
(B) Survival plot of Zmpste24/ mice fed an MR diet (pink) or CD (black) (n = 8 per group). Survival curves were analyzed with the log-rank (Mantel-Cox) test
(p = 0.0029) and Gehan-Breslow-Wilcoxon test (p = 0.008).
(C)Zmpste24/MRmice showahealthier aspect,manifestedby a reduced loss of hair and improved cervicothoracic lordokyphosis, thanZmpste24/CDmice.
(D and E) Taurine-conjugated BAs in (D) liver and (E) ileum samples from WT and Zmpste24/ female mice (n = 4 per group). Levels represent the log2 of the
normalized area in a.u. TaMCA, tauro-a-muricholic acid; TCDCA, taurochenodeoxycholic acid; TCA, taurocholic acid; TDCA, taurodeoxycholic acid; TLCA,
taurolithocholic acid; TUDCA, tauroursodeoxycholic acid.
(F) Zmpste24/ mice fed a diet enriched in cholic acid (Zmpste24/ CA) show a retarded manifestation of the phenotype-associated hindlimb stiffness
compared to Zmpste24/mice fed the CD (Zmpste24/ control). Appearance of limb stiffness was analyzed with the log-rank (Mantel-Cox) test (p = 0.001) and
Gehan-Breslow-Wilcoxon test (p = 0.0089) (n = 10 per group).
(G) Zmpste24/ CA mice (right) show a healthier aspect, manifested by a bigger size, reduced loss of hair, and improved cervicothoracic lordokyphosis,
compared to Zmpste24/ control mice (left).
(H) Survival plot of Zmpste24/ CA mice (n = 10) and Zmpste24/ control mice (n = 10). Survival curves were analyzed with the log-rank (Mantel-Cox) test
(p = 0.0011) and Gehan-Breslow-Wilcoxon test (p = 0.0012).
*p < 0.05; **p < 0.01. See also Figure S6 and Video S1.MRDiet and In Vivo BA Supplementation Extends Health
Span and Lifespan in Zmpste24 Null Progeroid Mice
We explored whether the effects of MR observed in our
LmnaG609G/G609G progeroid model could be reproduced in a
different mousemodel of premature aging and whether the alter-
ations in BAswere also shared by different progeroidmice. Thus,
we first evaluated the effect of MR in the Zmpste24/ mouse
model, deficient in the protease ZMPSTE24, which processes
prelamin A into mature lamin A (Navarro et al., 2005;
Penda´s et al., 2002). As observed in LmnaG609G/G609G mice,Zmpste24/ under MR (Zmpste24/ MR) also showed im-
provements in health and survival. Despite their reduced size
(Figure 6A), Zmpste24/ MR mice had a 21% increase in me-
dian survival and an almost 28% increase in maximal survival
(Figures 6B and S6A) and showed a healthier aspect, mostly
apparent by a reduced loss of hair and improved atrophy of hin-
dlimbs (Figures 6C and S6B).
Targeted metabolomics showed no differences in the levels
of primary BAs in liver and ileum of Zmpste24/ mice under
re-feeding conditions in a CD (Figures S6C and S6D);Cell Reports 24, 2392–2403, August 28, 2018 2399
Figure 7. Effect of MR in Progeroid Mice
Mouse models of HGPS, such as LmnaG609G/G609G
and Zmpste24/, show increased systemic
inflammation and hyperactivation of the DNA dam-
age response (DDR) pathways when mice are
maintained on a CD. The LmnaG609G/G609G mouse
model also shows a deregulation of both lipid and
BA levels. MR decreases the transcriptional activa-
tion of those stress pathways, restores lipid levels,
and changes BA levels and conjugation. The atten-
uation of both transcriptional and metabolic alter-
ations by MR increases health span and lifespan in
both progeroid mouse models.however, and similarly to LmnaG609G/G609G mice, these proge-
roid mice showed a significant increment in taurine conjuga-
tion (Figures 6D and 6E). These results indicate that progeroid
mice have a common increment of taurine-conjugated BAs.
MR shifted BA conjugation from an increase in taurine- to
glycine-conjugated BAs (Figures 5E and 5F), which is indepen-
dent of changes in primary BA synthesis after refeeding,
opposite to the increase in primary BAs observed in fasting
conditions. Based on these results, we hypothesize that BA
supplementation could normalize BA levels and improve their
health span. Therefore, we treated our Zmpste24/ progeroid
model, where health span is easier to assess than in
LmnaG609G/G609G due to their longer survival, with the main pri-
mary BA, cholic acid. Zmpste24/ mice kept on a diet en-
riched with 0.1% cholic acid (Zmpste24/ CA) had a delayed
appearance of the phenotype-associated hindlimb stiffness
and a consequent improvement in their daily movement
when compared to Zmpste24/ mice fed a normal diet
(Zmpste24/ control) (Figures 6F and S6E; Video S1). Also,
Zmpste24/ CA had a milder loss of weight during the pro-
gression of the phenotype (Figure S6F). The healthier status
of CA-treated progeroid mice was also assessed by their
improved cervicothoracic lordokyphosis, reduced loss of
hair, and bigger size (Figure 6G), as well as by their enhanced
median survival (7%; Figure 6H) and tendency to an enhanced
maximal survival (Figure S6G).
Collectively, these results indicate that MR promotes a health-
ier phenotype and extends survival in two different mouse
models of progeria. Additionally, we have proved that in vivo
supplementation of cholic acid in the diet exerts beneficial ef-
fects in progeria, suggesting that modulation of BA metabolism
could have a key role regulating longevity in mice.
DISCUSSION
CR is the most effective intervention to prolong lifespan in
diverse organisms so far; however, its application in humans pre-
sents important barriers, as food deprivation is something that
not many people would accept to practice. This has led to the
development of CR mimetics (Madeo et al., 2014; Mercken
et al., 2012), although their use has limitations owing to the
diverse effects of CR throughout different tissues (Igarashi and
Guarente, 2016). In contrast, MR appears to be a simpler way
of effectively acting on metabolism; more importantly, it offers
a translational strategy that is easier to apply to humans (Mann2400 Cell Reports 24, 2392–2403, August 28, 2018et al., 1999; McCarty et al., 2009; Schmidt et al., 2016). The
simplicity of a modified diet and the lack of negative secondary
effects make this type of intervention a promising tool for future
treatments of human diseases.
In the present work, we demonstrate that an MR diet can
substantially rescue the pathologic phenotype observed in
both the LmnaG609G/G609G and the Zmpste24/ HGPS mouse
models. With an MR diet, we found an amelioration of the
most severely modified pathways, such as DNA repair and
inflammation, and the normalization of certain metabolic alter-
ations (Figure 7). Among the last, we detected a recovery in
metabolic pathways related to lipid metabolism, supporting
the role of lipid homeostasis in longevity (Schroeder and
Brunet, 2015). Also, we observed that LmnaG609G/G609G mice
have reduced levels of primary and secondary BAs in liver
and that MR induces an increment of them in both WT and pro-
geroid mice. Additionally, we found that both LmnaG609G/G609G
and Zmpste24/ progeroid mice have abnormally high levels
of taurine-conjugated BAs. Probably due to the deficiency in
taurine under MR (Elshorbagy et al., 2010), mice fed with this
diet have reduced taurine conjugation with increased glycine
conjugation. As a result, the excess of taurine-conjugated
BAs observed in progeroid mice is reverted. We also showed
that the addition of 0.1% cholic acid in the diet has a beneficial
outcome in both the health span and lifespan of an HGPS
mouse model. Previous studies have suggested a role of BAs
in the promotion of health and longevity in different organisms,
from lower eukaryotes to mammals. BAs—and, in particular,
lithocholic acid—extend longevity in yeast in an mTOR-inde-
pendent manner (Arlia-Ciommo et al., 2014; Goldberg et al.,
2010; Leonov et al., 2017). Also, loss of the bile-acid-like ste-
roids called dafachronic acids reduces fitness and lifespan in
C. elegans (Magner et al., 2013). Conversely, in the long-lived
Ghrhr/ mice, there is an increase in BA levels in bile, serum,
and liver (Amador-Noguez et al., 2007). In our study, we
observed that MR can substantially rescue the phenotype of
the HGPS mouse, and we suggest that this occurs, at least
in part, by modulating the BA profile. However, the exact mech-
anism by which MR affects BAs levels and improves health
span and lifespan remains to be elucidated.
Overall, we provide evidence that diet modulation can effec-
tively increase health and the lifespan, not only in a normal phys-
iological situation but also in two mouse models of accelerated
aging, hence opening the possibility for implementing diet-
based strategies for the treatment of these diseases.
EXPERIMENTAL PROCEDURES
Additional details and resources used in this work can be found in the Supple-
mental Experimental Procedures.
Mouse Models
LmnaG609G/G609G and Zmpste24/ mice in a C57BL/6N background were
generated by crossing heterozygous mice and genotyped in our laboratory
as previously described (Osorio et al., 2011; Varela et al., 2005). Mice were
bred in a specific pathogen-free (SPF) area, and the experiments were car-
ried out in a conventional area with exclusion barriers. Mice were caged
separately by sex and genotype and were checked daily for water and
food supplies, as well as for good physical condition. Experiments with
modified diets were initiated at 7 weeks of age. For the microarray analysis
and untargeted metabolomics under fasting conditions, 6 males per group
were sacrificed after 6 hr of fasting at 110 days of life and used to obtain
serum and tissue samples. For the BA profiling under refeeding conditions,
mice were fasted overnight and then allowed to feed ad libitum for 4 hr
before being sacrificed. All animal experiments were approved by the Com-
mittee for Animal Experimentation of the Universidad de Oviedo and were
performed in accordance with its guidelines, making every effort to minimize
the suffering of the mice.
Diet Treatment
Rodent diets used in this study were acquired from Research Diets. The con-
trol diet (A11051302) contains a 0.86% of methionine, whereas the methio-
nine-restricted diet (A11051301) contains 0.12% methionine. Cystine was
not added to the diets during their elaboration. Methionine-restricted and con-
trol diets were provided that combined solid and crushed pellets in all exper-
imental groups to facilitate the feeding of the mutant mice. A diet enriched in
cholic acid was prepared with a dried ground global diet (Envigo #2014S); it
was mixed with filtered water (0.8 mL/g) containing, in suspension, cholic
acid (Sigma, #C1129) to obtain a final concentration of 0.1% in the resulting
diet. The mixture was kneaded to form pellets that were allowed to dry over-
night in a hood, resulting in small pellets of soft consistency.
Histological Analysis
Tissues were fixed in 4%paraformaldehyde in PBS and stored in 70% ethanol.
Fixed tissueswere embedded in paraffin by standard procedures. Blockswere
sectioned (5 mm) and stained with H&E (stomach), orcein (aorta), or H&E with
Gomori trichrome (muscle).
Analysis of Bone Structure
All tibia samples were scanned by high-resolution micro-computed tomogra-
phy (SkyScan 1174, SkyScan, Kontich, Belgium). The parameters were
measured according to the American Society for Bone and Mineral Research
(ASBMR) histomorphometry nomenclature (Parfitt et al., 1987).
Metabolic and Movement Measurements
Metabolic parameters such as VO2, VCO2 and energy expenditure, as well as
daily movement, were obtained using the CLAMS Comprehensive Lab Animal
Monitoring System (Oxymax CLAMS, Columbus Instruments) and analyzed
following the manufacturer’s instructions. Mice were monitored for 48 hr,
and the first 24 hr were discarded in the analysis, as this was considered an
acclimation period.
Western Blot Analysis
Tissues were collected and immediately frozen in dry ice. Samples were pro-
cessed for western blotting using standardmethods. Antibodies against phos-
pho-P70S6K (Thr421/Ser424) (#9204), total P70S6K (#2708), phospho-AKT
(Ser473) (#9271), total AKT (#9272), phospho-AMPKa (#2531), and total
AMPKa (#2532) were obtained from Cell Signaling Technology, and a-Tubulin
(T6074) was obtained from Sigma.
IGF1 Analysis, Serum Fatty Acids, and Liver Triglycerides
IGF1 measurements were performed in serum with EDTA using an IGF1 ELISA
kit obtained from R&D Systems (MG100). Free fatty acids in serum wereassayed using the luminometric Free Fatty Acid Assay Kit from Abnova
(KA1667). Triglycerides in liver were assayed using the EnzyChrom Triglycer-
ide Assay Kit from BioAssay Systems (ETGA-200).
Microarray Profiling
Microarray profiling was performed as previously described (Osorio et al.,
2011), using a GeneChip Mouse Gene 1.0 ST Array (Affymetrix). Raw data
were processed with the RMAExpress program (http://RMAExpress.
bmbolstad.com), using default settings. Differentially expressed genes in
each condition were identified using the R/Bioconductor package limma
(Ritchie et al., 2015). A proportional Venn diagram was generated using nVenn
(http://degradome.uniovi.es/cgi-bin/nVenn/nvenn.cgi) (Pe´rez-Silva et al.,
2018). GSEA v2.2.0 and MSigDB release 5.1 (http://software.broadinstitute.
org/gsea/index.jsp) were used for pathway enrichment analysis. Weighted
enrichment scores were calculated with gene expression lists ranked by
signal-to-noise ratio (maximum gene set size: 500; minimum gene set size:
20; number of permutations: 1,000; gene set database: Hallmark; false discov-
ery rate [FDR] # 0.25; and p # 0.01). Plots representing GSEA NESs were
generated using GraphPad Prism 6.0.
Untargeted and Targeted Metabolomics Analysis
Metabolites were extracted from 30 mg of each tissue using a mix of cold
methanol/water/chloroform (9:1:1). Samples were homogenized, and phase
separation was performed by centrifugation. For untargeted metabolomics,
supernatants were collected and evaporated, and dried extracts were solubi-
lized in methanol. Two aliquots were produced for gas chromatography-mass
spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-
MS) analysis. For targeted metabolomics, collected supernatants were evap-
orated, dried, and solubilized with MilliQ water. One aliquot was transferred to
LC vials and injected into LC-MS. Targeted metabolomics were performed us-
ing ultra-high-pressure liquid chromatography coupled to mass spectrometry
(UHPLC-MS). Analytical methods and data processingwere performed as pre-
viously described (Enot et al., 2015). Results were represented as the normal-
ized area of the MS picks in log2 scale using a.u. Normalization was performed
by correcting the area of the MS picks across the batches using the quality
control (QC) pooled samples (regularly injected during the analysis) and by
centering their values around the mean of the QC areas. Differentially ex-
pressed metabolites were identified using the R/Bioconductor package limma
(Ritchie et al., 2015). Metabolic pathway analysis was performed with Metab-
oAnalyst 3.0 (http://www.metaboanalyst.ca/) (Xia et al., 2015), using the hyper-
geometric test for representation analysis, and relative-betweenness centrality
was selected for pathway topology analysis. For targeted metabolomics,
statistical differences in BAs were calculated using a one-way ANOVA with
Tukey’s multiple comparison post hoc test, including sex as cofactor.
Statistical Analysis
Unless otherwise specified, all experimental data are reported as mean ±
SEM, except for the boxplots that were generated using Tukey’s method. Sta-
tistical differences were calculated using two-tailed Student’s t test for pair-
wise comparisons between two groups and one-way ANOVA with Tukey’s
correction for multiple comparisons for more than two groups. Survival
analysis was performed by using the Kaplan-Meier method, and statistical dif-
ferences were analyzed with the log-rank (Mantel-Cox) test and Gehan-Bre-
slow-Wilcoxon test. Power analysis of survival was 80%. Mortality rate was
calculated using the Gompertz model. Statistical differences between mortal-
ity curves was calculated using the extra-sum-of-squares F test. Maximal sur-
vival was analyzed using one-tailed Fisher’s exact test at the 80th percentile
(Wang et al., 2004). All statistical tests, data analysis, and plots were generated
using R and RStudio (R Core Team, Vienna, Austria, https://www.r-project.org;
RStudio Team, Boston, MA, USA, https://www.rstudio.com) and GraphPad
Prism 6.0. Plots and figures were modified using Adobe Illustrator CC.
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